{
    "nctId": "NCT02567214",
    "officialTitle": "Indacaterol 110\u00b5g/ Glycopyrronium 50\u00b5g (Ultibro\u00ae) Versus Tiotropium (Spiriva\u00ae) Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD",
    "inclusionCriteria": "1. Age \\> 50 years\n2. Smoking history \\> 10 packs/year\n3. FEV1 30 - 79% of predicted and FEV1/FVC \\< 70% (GOLD 2-3)\n4. FRC \\> 120 % predicted\n5. Borg dyspnea score \\> 3 during the 3-min constant rate shuttle walking test at V3\n* Must have minimum age of 51 Years",
    "exclusionCriteria": "1. Respiratory exacerbation within the 2 months preceding the study\n2. Current diagnostic of asthma\n3. Significant O2 desaturation (SpO2 \\< 85%) at rest or during exercise\n4. Presence of another pathology that could influence exercise tolerance\n5. Use of home oxygen"
}